New therapeutic effects of cilostazol in patients with ischemic disorders

Publisher： Bentham Science Publishers

E-ISSN： 1875-6212|13|3|399-404

ISSN： 1570-1611

Source： Current Vascular Pharmacology, Vol.13, Iss.3, 2015-05, pp. : 399-404

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Platelet activation markers, microparticles and soluble adhesion molecules are elevated in patients with arteriosclerosis obliterans: therapeutic effects by cilostazol and potentiation by dipyridamole

By Nomura Shosaku   Iwasaka Toshiji   Liu Yongge   Inami Norihito  

Platelets, Vol. 15, Iss. 3, 2004-05 ,pp. : 167-172

Informa Healthcare

Access to resources Recommend Favorite

Antiplatelet Cilostazol Is Beneficial in Diabetic and/or Hypertensive Ischemic Stroke Patients

By  

Cerebrovascular Diseases, Vol. 26, Iss. 1, 2008-05 ,pp. : 63-70

Karger

Access to resources Recommend Favorite

Antiplatelet Cilostazol Is Effective in the Prevention of Pneumonia in Ischemic Stroke Patients in the Chronic Stage

By  

Cerebrovascular Diseases, Vol. 22, Iss. 1, 2006-04 ,pp. : 57-60

Karger

Access to resources Recommend Favorite

Combined Therapeutic Effect of Probucol and Cilostazol on Endothelial Function in Patients with Silent Cerebral Lacunar Infarcts and Hypercholesterolemia: A Preliminary Study

By  

Medical Principles and Practice, Vol. 23, Iss. 1, 2013-11 ,pp. : 59-65

Karger

Access to resources Recommend Favorite

Laboratory characteristics of ischemic stroke patients with atrial fibrillation on or off therapeutic warfarin

By  

Clinical Cardiology, Vol. 40, Iss. 12, 2017-12 ,pp. : 1347-1351

John Wiley & Sons Inc

Access to resources Recommend Favorite